Stay updated on Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2; removed the 'Back to Top' element. No other substantive changes detected.
    Difference
    0.2%
    Check dated 2025-09-16T05:33:21.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-09T01:13:22.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new medical topics related to bladder cancer and urologic diseases. Notably, the version has been updated from v2.16.12 to v3.0.0.
    Difference
    4%
    Check dated 2025-09-01T21:08:57.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-18T13:52:08.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-11T09:28:37.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1.0%
    Check dated 2025-08-04T07:19:36.000Z thumbnail image

Stay in the know with updates to Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.